M

MaxCyte Inc
LSE:MXCT

Watchlist Manager
MaxCyte Inc
LSE:MXCT
Watchlist
Price: 1.55 GBX -3.73% Market Closed
Market Cap: 155.6m GBX

Intrinsic Value

The intrinsic value of one MXCT stock under the Base Case scenario is 2.68 GBX. Compared to the current market price of 1.55 GBX, MaxCyte Inc is Undervalued by 42%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MXCT Intrinsic Value
2.68 GBX
Undervaluation 42%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation History
MaxCyte Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about MXCT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MXCT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for MaxCyte Inc.

Explain Valuation
Compare MXCT to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MXCT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
MaxCyte Inc

Current Assets 124.6m
Cash & Short-Term Investments 105.7m
Receivables 8.3m
Other Current Assets 10.6m
Non-Current Assets 88.8m
Long-Term Investments 52.3m
PP&E 29.8m
Intangibles 4.2m
Other Non-Current Assets 2.6m
Current Liabilities 16.1m
Accounts Payable 1.3m
Accrued Liabilities 9.6m
Other Current Liabilities 5.2m
Non-Current Liabilities 17.1m
Other Non-Current Liabilities 17.1m
Efficiency

Free Cash Flow Analysis
MaxCyte Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
MaxCyte Inc

Revenue
34.4m USD
Cost of Revenue
-6.9m USD
Gross Profit
27.5m USD
Operating Expenses
-77.3m USD
Operating Income
-49.8m USD
Other Expenses
4.1m USD
Net Income
-45.6m USD
Fundamental Scores

MXCT Profitability Score
Profitability Due Diligence

MaxCyte Inc's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Declining Gross Margin
22/100
Profitability
Score

MaxCyte Inc's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

MXCT Solvency Score
Solvency Due Diligence

MaxCyte Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
64/100
Solvency
Score

MaxCyte Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MXCT Price Targets Summary
MaxCyte Inc

Wall Street analysts forecast MXCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MXCT is 7.01 GBX with a low forecast of 5.47 GBX and a high forecast of 10.24 GBX.

Lowest
Price Target
5.47 GBX
253% Upside
Average
Price Target
7.01 GBX
353% Upside
Highest
Price Target
10.24 GBX
561% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

MaxCyte Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MXCT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MXCT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one MXCT stock?

The intrinsic value of one MXCT stock under the Base Case scenario is 2.68 GBX.

Is MXCT stock undervalued or overvalued?

Compared to the current market price of 1.55 GBX, MaxCyte Inc is Undervalued by 42%.

Back to Top